Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 


FORM 8-K

 


CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 5, 2006

 


Microtune, Inc.

(Exact name of registrant as specified in its charter)

 


 

Delaware   000-31029-40   75-2883117

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

2201 10th Street, Plano, Texas   75074
(Address of principal executive offices)   (Zip Code)

(972) 673-1600

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 1.01 Entry Into A Material Definitive Agreement.

On October 5, 2006, Microtune, Inc. (the “Company” or “Microtune”) and International Business Machines Corporation (“IBM”) entered into Amendment No. 2 (including a Fourth Amended and Restated Attachment No. 1) (collectively, the “Amendment”) to that certain Custom Sales Agreement dated as of June 13, 2000 (the “IBM Agreement”), which, among other things, extended the term of the IBM Agreement to December 31, 2008 and modified certain pricing and other contractual terms. The Amendment is dated to be effective as of September 29, 2006. The IBM Agreement governs the provision of semiconductor manufacturing services by IBM to Microtune on a purchase order basis. IBM has no obligation to supply products to the Company and the Company has no obligation to purchase products from IBM for any specific period or in any specific quantity, except as is set forth and agreed upon by the parties in a particular purchase order.

The foregoing description of the Amendment is qualified in its entirety by reference to the text of the Amendment, filed as Exhibit 10.1 hereto and incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

  (d) Exhibits

 

Exhibit
Number
 

Exhibit Title

10.1(†)   Amendment No. 2 to the Custom Sales Agreement between International Business Machines Corporation and the Registrant dated as of September 29, 2006.

 

Portions of this exhibit were omitted pursuant to a request for confidential treatment and filed separately.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    MICROTUNE, INC.

Date:

 

October 11, 2006

   

By:

 

/s/ Jeffrey A. Kupp

     

Name:

 

Jeffrey A. Kupp

     

Title:

 

Chief Financial Officer


EXHIBIT INDEX

 

Exhibit
Number
 

Exhibit Title

10.1(†)   Amendment No. 2 to the Custom Sales Agreement between International Business Machines Corporation and the Registrant dated as of September 29, 2006.

 

Portions of this exhibit were omitted pursuant to a request for confidential treatment and filed separately.